CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Overview of attention for article published in Frontiers in oncology, February 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 41 Dimensions

Readers on

mendeley: 55 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup. https://t.co/4FqIFdFO8n #colorectalcancer #oncology

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.